tiprankstipranks
Trending News
More News >
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD)
:RMD
Advertisement

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Stock Statistics & Valuation Metrics

Compare
147 Followers

Total Valuation

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has a market cap or net worth of AU$64.26B. The enterprise value is AU$57.29B.
Market CapAU$64.26B
Enterprise ValueAU$57.29B

Share Statistics

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has 1,464,148,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,464,148,300
Owned by Insiders
Owned by Institutions<0.01%

Financial Efficiency

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)
Return on Assets (ROA)
Return on Invested Capital (ROIC)
Return on Capital Employed (ROCE)
Revenue Per Employee515.66K
Profits Per Employee140.35K
Employee Count9,980
Asset Turnover
Inventory Turnover

Valuation Ratios

The current PE Ratio of Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh is 30.7. Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s PEG ratio is 2.01.
PE Ratio30.7
PS Ratio5.87
PB Ratio5.65
Price to Fair Value
Price to FCF21.37
Price to Operating Cash Flow23.92
PEG Ratio2.01

Income Statement

In the last 12 months, Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh had revenue of 5.15B and earned 1.40B in profits. Earnings per share was 0.96.
Revenue5.15B
Gross Profit3.05B
Operating Income1.69B
Pretax Income1.68B
Net Income1.40B
EBITDA1.92B
Earnings Per Share (EPS)0.96

Cash Flow

In the last 12 months, operating cash flow was 1.75B and capital expenditures -96.05M, giving a free cash flow of 1.66B billion.
Operating Cash Flow1.75B
Free Cash Flow1.66B
Free Cash Flow per Share1.13

Dividends & Yields

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh pays an annual dividend of AU$0.093, resulting in a dividend yield of 0.76%
Dividend Per ShareAU$0.093
Dividend Yield0.76%
Payout Ratio22.67%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.91
52-Week Price Change25.24%
50-Day Moving Average41.29
200-Day Moving Average38.07
Relative Strength Index (RSI)58.35
Average Volume (3m)1.08M

Important Dates

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh upcoming earnings date is Oct 23, 2025, After Close (Confirmed).
Last Earnings DateJul 31, 2025
Next Earnings DateOct 23, 2025
Ex-Dividend DateAug 13, 2025

Financial Position

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh as a current ratio of ―, with Debt / Equity ratio of 14.78%
Current Ratio
Quick Ratio
Debt to Market Cap
Net Debt to EBITDA
Interest Coverage Ratio

Taxes

In the past 12 months, Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has paid 276.84M in taxes.
Income Tax276.84M
Effective Tax Rate

Enterprise Valuation

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales
EV to EBITDA
EV to Free Cash Flow
EV to Operating Cash Flow

Balance Sheet

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh has AU$1.21B in cash and marketable securities with AU$839.77M in debt, giving a net cash position of -AU$357.64M billion.
Cash & Marketable SecuritiesAU$1.21B
Total DebtAU$839.77M
Net Cash-AU$357.64M
Net Cash Per Share-AU$0.24
Tangible Book Value Per Share

Margins

Gross margin is 59.36%, with operating margin of ―, and net profit margin of ―.
Gross Margin59.36%
Operating Margin
Pretax Margin
Net Profit Margin
EBITDA Margin
EBIT Margin

Analyst Forecast

The average price target for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh is AU$46.71, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetAU$46.71
Price Target Upside6.04% Upside
Analyst ConsensusStrong Buy
Analyst Count10
Revenue Growth Forecast11.26%
EPS Growth Forecast39.47%

Scores

Smart Score10
AI Score80.6
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis